The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP4186502
WO Application Number:
Type:
European Patent Granted for NL
Status:
Deemed not to be granted according to art. 52.4a or 52.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP23152614.6
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
13/02/2020
Grant date:
10/09/2025
EP Publication Date:
31/05/2023
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
10/09/2025
EP B1 Publication Date:
10/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/02/2040
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
10/09/2025
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
10/09/2025
Name:
Vanda Pharmaceuticals Inc.
Address:
2200 Pennsylvania Ave NW
Suite 300E, Washington, DC 20037, United States of America (US)
Inventor
1
Name:
POLYMEROPOULOS, Mihael
Address:
Potomac, 20854, United States of America (US)
2
Name:
SMIESZEK, Sandra
Address:
Washington DC, 20037, United States of America (US)